Guggenheim Capital LLC Infinity Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$1.72 - $2.26 $23,199 - $30,482	-13,488 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.8 - $2.74 $147 - $224	82 Added 0.61%	13,488 $28,000
Q4 2017 Feb 14, 2018	SELL	$1.22 - $3.73 $2,042 - $6,244	-1,674 Reduced 11.1%	13,406 $27,000
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $14,175 - $20,358	15,080	15,080 $20,000

1.27M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.